6186N Stock Chart & Stats
$13.58
$0.00(0.00%)
At close: 4:00 PM EDT
$13.58
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$13.58 - $13.58
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$54.98B
Enterprise Value$9.55K
Total Cash (Recent Filing)$15.39B
Total Debt (Recent Filing)$541.21M
Price to Earnings (P/E)11.9
Beta-0.98
Next Earnings
Apr 01, 2027EPS Estimate
0.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.20
Shares Outstanding9,067,252,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)1.35
Price to Sales (P/S)1.82
P/FCF Ratio51.31
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$7.60Price Target Upside-44.07% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)0.47
Revenue Forecast (FY)$39.67B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low leverage and sizable equity backing provide financial resilience through weaker operating periods. The conservative capital structure preserves borrowing capacity and reduces interest-related pressure, supporting continued investment in products, distribution and quality control.
High Gross MarginA high gross margin indicates that Feihe retains meaningful economics in its branded nutritional products. Although profitability weakened, this margin base can support marketing, research and development, and distribution investment if sales stabilize.
Branded And Integrated Business ModelFeihe's branded infant-nutrition portfolio and integrated sourcing and production model can support product quality, supply reliability and cost control. These capabilities may strengthen consumer trust and defend margins over multiple reporting periods.
Bears Say
Revenue ContractionA substantial annual revenue decline signals weaker demand, distribution or product mix in the core business. Unless growth returns, lower scale can reduce operating leverage and constrain the company's ability to absorb fixed manufacturing, marketing and research costs.
Margin CompressionThe sharp reduction in net margin indicates that earnings are becoming less efficient despite still-strong gross margins. Persistent pricing, mix or cost pressure would weaken reinvestment capacity and make future earnings more dependent on a recovery in revenue.
Weak Cash ConversionFree cash flow was only about 29% of net income in 2025, versus 64% in 2024, while operating cash flow also declined. This weaker conversion suggests working-capital or investment demands are absorbing earnings and could limit durable cash returns.
China Feihe Limited News
6186N FAQ
What was China Feihe Limited’s price range in the past 12 months?
China Feihe Limited lowest stock price was $13.58 and its highest was $13.58 in the past 12 months.
What is China Feihe Limited’s market cap?
China Feihe Limited’s market cap is $54.98B.
When is China Feihe Limited’s upcoming earnings report date?
China Feihe Limited’s upcoming earnings report date is Apr 01, 2027 which is in 204 days.
How were China Feihe Limited’s earnings last quarter?
China Feihe Limited released its earnings results on Aug 26, 2026. The company reported $0.228 earnings per share for the quarter, missing the consensus estimate of $0.354 by -$0.126.
Is China Feihe Limited overvalued?
According to Wall Street analysts China Feihe Limited’s price is currently Overvalued.
Does China Feihe Limited pay dividends?
China Feihe Limited does not currently pay dividends.
What is China Feihe Limited’s EPS estimate?
China Feihe Limited’s EPS estimate is 0.26.
How many shares outstanding does China Feihe Limited have?
China Feihe Limited has 9,067,252,000 shares outstanding.
What happened to China Feihe Limited’s price movement after its last earnings report?
China Feihe Limited reported an EPS of $0.228 in its last earnings report, missing expectations of $0.354. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of China Feihe Limited?
Currently, no hedge funds are holding shares in MX:6186N
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
China Feihe Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-31.36%
12-Months-Change
Fundamentals
Return on Equity
7.76%
Trailing 12-Months
Asset Growth
7.56%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
China Feihe Limited
China Feihe Limited operates as an investment holding entity primarily engaged in the production and sale of infant formula, serving consumers across Mainland China and the United States. Its comprehensive product portfolio extends to include raw and liquid milk, adult milk powders, various healthcare products, and specialized powders like soybean and goat milk. Furthermore, the company retails vitamins, minerals, herbal supplements, and other nutritional items. Products reach consumers through a multi-channel approach, utilizing third-party distributors, prominent e-commerce platforms such as Tmall, JD.com, and Suning.com, alongside its official website and mobile applications, including WeChat. By December 31, 2021, its extensive distribution network involved approximately 2,000 offline customers, managing 110,000 retail points of sale. China Feihe Limited was established in 1962 and is headquartered in Beijing, People's Republic of China.
6186N Stock 12 Month Forecast
Average Price Target
$7.60
▼(-44.07% Downside)